Yahoo Web Search

Search results

1. finance.yahoo.com › news › teva-pharmaceutical-industriesTeva Pharmaceutical Industries Limited (NYSE:TEVA) is favoured by...

   finance.yahoo.com › news › teva-pharmaceutical-industries

   • Cached

   5 days ago · Significantly high institutional ownership implies Teva Pharmaceutical Industries' stock price is sensitive to their trading actions The top 25 shareholders own 47% of the company Using data from ...

2. markets.businessinsider.com › news › stocksAnalysts Conflicted on These Healthcare Names: Teva...

   markets.businessinsider.com › news › stocks

   • Cached

   1 day ago · Bank of America Securities analyst Jason Gerberry maintained a Buy rating on Teva Pharmaceutical today and set a price target of $22.00. The company’s shares closed last Thursday at $17.82 ...

3. www.fitchratings.com › research › corporate-financeFitch Upgrades Teva's Long-Term IDR to 'BB'; Outlook Positive

   www.fitchratings.com › research › corporate-finance

   • Cached

   2 days ago · Teva is a global pharmaceutical company operating worldwide with headquarters in Israel and a significant presence in the U.S., Europe and other markets around the world. Its key strengths include world-leading generic medicines expertise and portfolio, a focused specialty medicines portfolio and global infrastructure and scale.

4. www.fiercepharma.com › pharma › europes-chmp-turns-down-apEurope's CHMP turns down Apellis' pegcetacoplan appeal, endorses...

   www.fiercepharma.com › pharma › europes-chmp-turns-down-ap

   • Cached

   23 hours ago · Pharma Europe's CHMP turns down Apellis' pegcetacoplan appeal, endorses new drugs from Pfizer, ImmunoGen and Henlius By Fraiser Kansteiner Sep 20, 2024 10:06am

5. Videos

   • 

     1:11

     youtube.com

     Teva Pharmaceuticals: We Are All In for Better Health

     21 Dec 2023

     3.3K views

   • 

     2:26

     youtube.com

     Teva Pharmaceutical: Putting people first

     23 Mar 2022

     3.9K views

   • 

     6:37

     bloomberg.com

     WATCH: Teva Pharmaceutical Industries CEO Richard Francis says the company is going to make fewer generic drugs and will make more new, branded products.

     18 May 2023

   View all

6. simplywall.st › stocks › usTeva Pharmaceutical Industries NYSE:TEVA Stock Report - Simply...

   simplywall.st › stocks › us

   • Cached

   2 days ago · Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally.

   • 52 Week High: US$18.89
   • Beta: 0.88

   • 52 Week Low: US$8.06
   • Current Share Price: US$18.87

7. www.marketscreener.com › quote › stockTeva Pharmaceutical Industries Limited Stock - MarketScreener.com

   www.marketscreener.com › quote › stock

   • Cached

   3 days ago · Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products.

8. www.medscape.com › viewarticle › triptans-trump-newer-moreTriptans Trump Newer, More Expensive Meds for Acute Migraine -...

   www.medscape.com › viewarticle › triptans-trump-newer-more

   • Cached

   1 day ago · Ashina is a consultant, speaker, or scientific advisor for AbbVie, Amgen, AstraZeneca, Eli Lilly, GSK, Lundbeck, Novartis, Pfizer, and Teva; is the past president of the International Headache ...